Results
Lymphocytes harvested from MSC-PBMC co-cultures strongly inhibit (up to 95%) mixed lymphocyte reaction (MLR), recall to alloantigen, and CD3-or phytohemagglutinin-induced lymphocyte proliferation. These lymphocytes, termed regulatory cells (Regc), were all CD45 +
CD2
+ with variable proportions of CD25 + cells (range 40-75% n=10) and a minor fraction expressed CTLA4 (2-4%, n=10) or glucocorticoid-induced tumor necrosis factcor receptor-related gene (0.5-4% n=10). Both CD4 + and CD8 + Regc purified from MSC-PBMC co-cultures strongly inhibited lymphocyte proliferation at a 1:100 Regc:responder cell ratio. CD4 + Regc expressed high levels of forkhead box P3 (Foxp3) mRNA while CD8 + Regc did not. The effectiveness of Regc, whether CD4 + or CD8 + , was 100-fold higher than that of CD4 + CD25 +high regulatory T cells. Regc were also generated from highly purified CD25 -PBMC or CD4 + or CD8 + T cell subsets. Soluble factors, such as interleukin-10, transforming growth factor-β and prostaglandin E2 did not appear to be involved in the generation of Regc or in the Regc-mediated immunosuppressive effect. Furthermore, cyclosporine A did not affect Regc generation or the immunosuppression induced by Regc. B one marrow mesenchymal stem cells (MSC) are able to give rise, under appropriate culture conditions, to osteoblasts, chondrocytes, adipocytes and even neurons. [1] [2] [3] [4] [5] [6] Thus, it has been proposed to use MSC to repair injured tissues, or after appropriate manipulation, to treat inherited disorders. [1] [2] [3] [4] [5] [6] In addition, several studies have shown that MSC can also exert a tolerogenic effect. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Indeed, MSC inhibit lymphocyte proliferation in mixed lymphocyte reaction (MLR) when added as a third party as well as T lymphocyte proliferation in response to polyclonal mitogenic stimuli. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The administration of MSC was found to abolish graft-versus-host disease (GVHD) in a young patient who underwent bone marrow transplantation, strongly suggesting that these cells could be used in vivo as regulators of the immune response. 17 The MSC-mediated immunosuppressive effect is thought to be dependent on soluble factors released by these cells, such as transforming growth factor (TGF)-β 8 , hepatocyte growth factor (HGF) 8 , prostaglandin E2 (PGE2) 15 or metabolites of tryptophan generated by activation of indoleamine-dioxigenase (IDO) present in MSC. 14 It is commonly accepted that immunosuppression can be accomplished by lymphocyte populations termed regulatory T cells. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] The regulatory T-cell population resides mainly within the CD4 + T-cell subset namely: CD4 + CD25 +high forkhead box P3 + (Foxp3 + ) (Treg) cells, CD4 + IL10 + Foxp3 -(Tr1) cells, and CD4 + TGF-β + (Th3) cells. 27, [30] [31] [32] [33] In addition, also CD8 + T-cell subsets such as CD8 + CD25 + , CD8 + CD28 -and CD8 + IL-10 + can down-regulate lymphocyte activation and proliferation. 27, [30] [31] [32] [33] The suppressive mechanism can involve the direct interaction of a given regulatory subset and responder lymphocytes and/or the release, by the regulatory cells of immune regulating cytokines including TGF-β or IL10 [30] [31] [32] [33] which inhibit lymphocyte response. A role of regulatory cells in MSC-mediated immunosuppression has been suggested by the increment of CD4 + CD25 + CTLA4 + cells found in co-cultures of allogeneic MSC when added to MLR as a third party. 34 Thus, besides soluble mediators released by MSC, the MSCmediated immunosuppressive effect could be amplified by the action of Treg. However, it is not clear whether CD4 + CD25 + CTLA4 + cells obtained from co-culture of MSC in MLR may function as Treg and, if so, their effectiveness, and whether these putative Treg are generated only when MSC are added as a third party to MLR. In this study, we investigated whether MSC induce by themselves, in co-cultures with lymphocytes, the generation of highly effective regulatory cells expressing either CD4 or CD8. Regulatory activity, compared to that of conventional CD4 + Treg cells was analyzed in MLR, recall to alloantigen as well as CD3-or phytohemagglutinin(PHA)-driven T-cell proliferation.
Results

Inhibition of lymphocyte proliferation by lymphocytes harvested from MSC-PBMC co-cultures.
We first analyzed whether, in MSC-PBMC co-cultures, MSC could induce the generation of cells with regulatory/immunosuppressive activity. To this aim, MSC were cultured with PBMC for 4 days then cells were harvested and added to primary MLR and cell proliferation was analyzed by 3 H thymidine uptake on day 7 ( Figure 1A) . We found that the addition of cells from MSC-PBMC co-cultures to MLR strongly inhibited cell proliferation (range of inhibition 65-95%, n=5). On this basis, these cells were thereafter termed regulatory cells (Regc). This effect was evident not only at 1:1 and 1:10 but also at 1:100 Regc: responding ( R) PBMC ratios (60-80% range of inhibition, n=5) and it was still detectable at 1:250 to 1:500 Regc:R ratios (45-55% of inhibition, n=3). Comparable results were also obtained when analyzing proliferation after staining of responding cells with CFSE (not shown). Regc were generated from PBMC-MSC co-cultures using autologous ( Figure 1 ) or allogeneic MSC (not shown).
Given the down-regulating effect of Regc on MLR, we next explored whether these cells could also affect lymphocyte proliferation to recall of alloantigen. To this aim, Regc were added to secondary MLR and proliferation was analyzed on day 3 after the second challenge with stimulating PBMC. We found that, Regc down-regulated cell proliferation to recall of alloantigen ( Figure 1B) as well: indeed, at a 1:100 Regc:responder lymphocyte ratio, there was a 69-95% inhibition (n=4) of the second response to alloantigen. Furthermore, Regc could down-regulate CD3-( Figure 1C ) or PHA-mediated triggering ( Figure 1D ). The close interaction between Regc and responding cells was necessary to achieve the inhibition of either MLR or recall to alloantigen or CD3-driven activation, as Regc had no effect on lymphocyte proliferation when they were separated from responder PBMC by a porous filter in Millicell chambers ( Figure 1A-D) . Furthermore, the addition to MLR or secondary MLR or CD3-stimulated PBMC of either unstimulated PBMC or lymphocytes activated for 4 days with either PHA or anti-CD3 monoclonal antibody (mAb), at the same ratios used above, did not affect lymphocyte proliferation (not shown). It is of note that the generation of Regc in co-culture of lymphocytes and MSC was achieved only when there was a close interaction between these two cell populations. Indeed, no Regc were harvested from PBMC-MSC co-cultures when these cells were separated from each other by a transmembrane porous filter in a Millicell chamber (not shown).
Regc are represented by CD4
+ and CD8 + lymphocytes
On the basis of the ability of Regc generated in MSC-PBMC co-cultures to down-regulate lymphocyte proliferation, we explored whether these cells can express markers typical of CD4 + Treg. [30] [31] [32] [33] We found that Regc were all CD45 + and that the large majority of them were T cells as they expressed CD3 and CD2 antigens (95-98%, Table 1 ). Furthermore, a large proportion of Regc were CD4 + (57-75%), a fraction expressed CD8 (35-45%) while only a minor fraction expressed markers of CD4 + Treg, such as CTLA-4 (analyzed both at the cell surface and in the cytoplasm after cell permeabilization) and GITR ( Figure 2B ) or anti-CD3 mAb or PHA (not shown) when added to cell cultures at the same ratios used for Regc. Both CD8 + and CD4 + cells, obtained from MSC-PBMC co-cultures and purged of possible contaminating MSC by immunodepletion with anti-CD105 mAb, exerted a strong inhibition (80-95%, n=5) on lymphocyte proliferation regardless of the stimulus used (anti-CD3 mAb or PHA, Figure 2C ; or MLR, not shown). Finally, we analyzed whether the expression of the Foxp3 transcription factor, typical of Treg, was increased in MSC-PBMC co-cultures and in which lymphocyte population. A two to three fold increase in Foxp3 mRNA expression was found in MSC-PBMC co-cultures compared to PBMC alone ( Figure 2D ). This increase was not detected when CD25 -PBMC were co-cultured with MSC ( Figure 2D ), although Regc derived from CD25 -PBMC-MSC co-cultures can inhibit cell proliferation ( Figure 2A) . Furthermore, the finding that the degree of regulatory activity was independent of the expression of Foxp3 mRNA was confirmed in different Regc populations. Indeed, CD8 + Regc expressed a lower level of Foxp3 than PHA-activated lymphocytes ( Figure 2D ) but, unlike PHA blasts, they strongly down-regulated lymphocyte proliferation ( Figure 2D ) but the regulatory activity of these two different cell populations was comparable ( Figure 2C ).
MSC stimulate PBMC and T-cell subsets to produce IL10 and TGFβ‚ immune-regulating cytokines.
The generation of Regc in co-cultures of MSC with lymphocytes prompted us to determine whether immuneregulating cytokines, such as IL10 or TGF-β, were responsible for this effect. First, we analyzed whether these two cytokines were released in MSC-lymphocyte co-cultures. Secretion of IL10 and TGF-β in culture supernatants harvested from co-cultures of PBMC with MSC was analyzed after 24 hours of incubation. High levels of the immunosuppressive cytokine IL10 were found in MSC-PBMC co-culture supernatants ( Figure 3A) while the amount of TGF-β was similar to that produced by MSC alone ( Figure 3B ). Less than 30 pg/mL of TGF-β were detected in the complete medium (not shown). In the presence of MSC, IL10 was secreted at 50 to 200-fold higher amounts than upon anti-CD3 mAb stimulation or MLR (not shown). To determine whether MSC can trigger a subset of PBMC to produce IL10, we performed co-cultures of MSC with purified T, CD4 + or CD8 + T lymphocytes. Highly purified ex vivo isolated T (99-100%, n=4), CD4 + T (96-100%, n=4) and CD8 + T (95-100%, n=4) cells were obtained by negative selection. We found that both unfractionated T cells, CD4 + or CD8 + T lymphocyte subsets co-cultured with MSC can produce IL10 although at a lower level compared to unfractionated PBMC. Next, we determined whether contact between either PBMC or lymphocyte subsets and MSC was necessary to induce lymphocyte activation. To this aim, PBMC or T-cell subsets were seeded in Millicell filter chambers in culture plates separated from MSC adherent at the bottom of culture wells. Parallel experiments with lymphocytes and MSC in direct contact were performed as a control. The presence of IL10 in culture supernatants was thus analyzed after 24 hours of incubation (Figure 3) . Secretion of this cytokine was strongly reduced (>90% inhibition) when responder cells (PBMC, or T or CD4 + or CD8 + cells) were separated from MSC by the porous filter of Millicell chambers ( Figure 3C ). Furthermore, we analyzed the surface molecular structures responsible for the delivery of the triggering signal to PBMC or T-cell subsets.
To this aim, a series of co-culture experiments was performed in the presence of mAb directed to surface receptor/ligand pairs including CD2/LFA2-CD58/LFA3 and CD11a/LFA1-CD54/ICAM1, possibly involved in cell to cell interaction. 22 As shown in Figure 3D , we determined that the interaction of CD2/LFA2 and CD58/LFA3 is responsible for the delivery of the activation signal that leads to cytokine production. Indeed, the addition of anti-CD2 and/or anti-CD58 mAb strongly inhibited (65-80%, n=4) the production of IL10 ( Figure 3D ) by T cells as well as CD4
+ and CD8 + T-cell subsets. On the other hand, the addition of anti-CD11a/LFA1 mAb, alone or in combination with anti-CD54/ICAM1 mAb, had a lower inhibitory effect (range 25-35% in six independent experiments, not shown). The amount of TGF-β detected in culture supernatants did not change if lymphocytes and MSC were separated by a transwell or when the co-cultures were performed in the presence of anti-LFA3/CD58 mAb (data not shown). The addition of mAb specific for CD2 or CD58 or CD11a or CD54 (alone or in combination) neither inhibited nor induced the generation of Regc (not shown).
Comparison of CD4
+ or CD8 + Regc and CD4 + CD25 +
Treg effectiveness
We addressed the question of whether the effectiveness of the inhibition exerted by Regc was comparable to that of naturally occurring CD4 + CD25
+ Treg. As shown in Figure 4A 
Role of soluble factors in inducing the generation of Regc and Regc-mediated immunosuppression
We next analyzed whether IL10, TGF-β and PGE2 were involved in the generation of Regc as well as in the Regcmediated regulation of lymphocyte proliferation. Co-cultures of lymphocytes and MSC were performed in the presence of anti-IL10 and/or anti-TGF-β blocking antibodies and/or NS398, an inhibitor of PGE2 synthesis, to evaluate the effect of these soluble factors on Regc precursors (pCD4 + and pCD8 + of Figure 4C ). As shown in Figure  4C , the anti-IL10 and the anti-TGF-β antibodies, alone or in combination with the NS398 inhibitor (MIX), did not affect the generation of Regc ( Figure 4C ). We then determined whether IL10, TGF-β and PGE2 could be involved in the immunosuppressive mechanism mediated by Regc on lymphocyte proliferation.
Thus, the anti-IL10 and anti-TGF-β antibodies, alone or together with NS398, were added at the onset of the regulatory assay, in order to analyze the effect of each soluble factor on the function of Regc effector cells (eCD4 + and eCD8 + of Figure 4C ). Again, the blockade of IL10, TGF-β and PGE2 did not affect the Regc-mediated immunosuppressive effect on the stimulation by anti-CD3 ( Figure 4C ) or alloantigen or PHA (data not shown).
Effect of CSA on the generation of Regc and on Regc-mediated immunosuppression
Given the inhibiting effect of Regc on lymphocyte proliferation, we next explored whether the immunosuppressive drug CSA could affect Regc generation or Regcmediated immunosuppression. Indeed, CSA is administered to down-regulate lymphocyte response to prevent and treat graft-versus-host disease (GVHD). As MSC have been used for the treatment of GVHD, it is of relevance to determine whether CSA could reduce MSC-induced generation of Regc or immunosuppression exerted by Regc. When generated in the presence of CSA (500 ng/mL), CD4 + or CD8 + Regc still exerted a strong inhibiting effect on PHA-induced lymphocyte proliferation (up to 95% at a 1:100 Regc:responder cell ratio) comparable to that exerted by Regc generated without CSA ( Figure 4C) .
However, the inhibition of lymphocyte proliferation to anti-CD3 mAb or alloantigen exerted by Regc obtained in the presence of CSA (range of inhibition 50-85% n=4) was less effective than that displayed by Regc generated without CSA (range of inhibition 70-95%, n=4) (data not shown). Finally, we analyzed whether CSA could impair the immunosuppressive function of CD4 + or CD8 + Regc, pretreated with the drug, washed and added to the regulatory assay. We found that CSA treatment of Regc did not affect the Regc-mediated immunosuppression ( Figure 4C ).
Discussion
In this study, we have shown that MSC by themselves trigger the generation of highly effective CD4 + or CD8 
CD28
-regulatory T cells.
33
Several reports have claimed that MSC can exert a pleiotropic immunosuppressive effect down-regulating (i) lymphocyte proliferation in MLR, when MSC are added as a third party [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , and (ii) cytokine production by both antigen-presenting cells and T cells. 15 This effect was mainly ascribed to the production by MSC of cytokines (TGF-β 8 HGF
8
), metabolites (PGE2
15
) or enzymes (IDO).
14
The reported production of soluble factors and the consequent strong inhibition of MLR was observed after adding MSC, as a third party, to MLR at a MSC:PBMC ratio of 1:1 or 1:2. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] This raises a question: are these MSC:PBMC ratios achieved in vivo? Indeed, according to the immunosuppression observed in vivo, 17 relatively high numbers of MSC should be injected to obtain this effect. This may be of great relevance in planning the dose of MSC to administer. Here, we provide functional evidence that immunosuppression can also be produced by Regc generated upon interaction with MSC. This finding might explain the therapeutic effect observed in vivo following the injection of relatively low numbers of MSC compared to the number of lymphocytes present in a given patient.
17
The role of naturally occurring CD4 + CD25
+ Treg in MSC-mediated immunosuppressive effect is still controversial.
34,39 Indeed, Krampera et al. 39 reported that MSC induce a strong anti-proliferative effect not associated with any effect on enhancement of T regulatory activity. On the other hand, Maccario et al. 34 showed ). It is difficult to determine whether our CD4 + Regc or CD8 + Regc are novel populations of regulatory cells. Indeed, the findings that in our experimental system CD4 + Regc do not express CTLA4 and GITR, while CD8 + Regc express CD28 would suggest that Regc are different from some of the typical regulatory T cells described.
30-33,40
The possibility that residual contaminating MSC could be present within Regc populations, and thus they may have a role in inhibiting lymphocyte proliferation, is very unlikely as the whole population of Regc expressed the leukocyte marker CD45. Moreover, cells which do not express markers of MSC, such as CD105 or SH3 and SH4, can down-regulate lymphocyte proliferation. Finally, the number of MSC possibly present in a given Regc populations should be less than 1% (as this is the threshold of immunofluorescence), thus the ratio between MSC and responding lymphocytes should be 1:100.000, when Regc function at a Regc:responder cell ratio of 1:100. This number of MSC is not compatible with any inhibition of cell proliferation also according to the literature. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The molecular mechanism through which Regc can exert their potent regulatory effect remains to be elucidated. It has been proposed that Treg may down-regulate immune responses through direct interaction of CTLA4 on suppressor T cells and CD80 or CD86 on effector cells; 32, 33 this interaction may also occur between suppressor T cells and antigen-presenting cells leading to activation of IDO, reduction of extracellular free tryptophan and consequent inhibition of T-cell proliferation. 32, 33 Regc generated in our MSC-PBMC cocultures did not express CTLA4, making it unlikely that the above mentioned mechanism is primarily involved in mediating the immunosuppressive effect in this experimental system. Furthermore, Regc can exert their inhibiting effect independently of Foxp3 transcription factor expression, unlike what is observed for Treg. [30] [31] [32] [33] In our experimental system, the soluble factors IL10, TGF-β and PGE2 did not appear to be involved in Regc generation and Regc-mediated regulatory function. One could hypothesize that soluble factors other than TGF-β, IL10 and PGE2 are responsible for Regc-mediated effect. Indeed, we found that during MSC-lymphocytes co-cultures, high amounts of IFN-γ and TNF-α can be released; these cytokines may be involved in the regulation of cell proliferation (not shown). However, similar amounts of IFN-γ and TNF-α are released during alloantigen stimulation or triggering of lymphocytes with PHA or anti-CD3 mAb, suggesting that, if these cytokines are involved, they are not sufficient to explain the Regcmediated inhibiting effect. In addition, the regulation of lymphocyte proliferation may occur by induction of apoptosis. Indeed, we have found an increase of the number of apoptotic cells in lymphocyte cultures triggered with anti-CD3 mAb in the presence of Regc; experiments are in progress to determine the mechanism of this apoptotic event. Finally, a role for other mediators, such as adenosine, could be an alternative explanation for the potent IL10/TGF-β independent Regc-mediated regulation. It has been recently reported that adenosine can play a critical role in T-cell mediated regulation of inflammation in colitis by inhibiting the production of inflammatory cytokines without affecting IL10 and TGF-β secretion.
44
The frequency of cells with inhibiting activity within the populations of Regc is still to be determined. It is conceivable that a large fraction, and not a small subset, of lymphocytes derived from co-cultures with MSC display regulatory functions, as Regc can exert their regulating activity at very low Regc:responding cell ratios. It is of note that neither surface nor cytoplasmic markers expressed by conventional described subsets of regulatory cells 19, [30] [31] [32] are selectively present on Regc; this hampers the determination of the frequency of regulatory cells within Regc populations.
In conclusion, we could hypothesize that two different mechanisms of MSC-mediated immunosuppression might occur, depending on the ratio between MSC and responding cells: the first one mainly mediated by soluble factors (TGF-β and PGE2) during the interaction between MSC and lymphocytes at 1:1 and 1:10 MSClymphocyte ratios and the second one dependent on Regc generation evident at lower ratios, such as 1:2000. Thus, MSC may exert their immunosuppressive function directly through the release of factors such as TGF-β, HGF, IDO and PGE2 able to inhibit responder T-cell proliferation; on the other hand this immunosuppressive effect could be amplified by the generation of Regc. Importantly, the generation of Regc and the regulatory effect mediated by the different subpopulations of Regc appear to be independent of CSA treatment. This finding is of great relevance as CSA is commonly used in the prevention and treatment of GVHD, suggesting that CSA can co-operate with Regc in inducing immunosuppression when MSC are administered.
Finally, it has been recently reported that NK cells can regulate MSC survival.
37,41-43 Thus, one can hypothesize that NK cells would affect the generation of Regc by eliminating MSC and consequently regulating the MSC-mediated immunosuppressive effect. This should be considered when it is planned to administer MSC to patients in whom latent viral infections can be reactivated by immunosuppressive treatment. 
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